Astex Pharmaceuticals, Inc.

299 articles with Astex Pharmaceuticals, Inc.

• SuperGen, Inc. To Present At UBS Global Pharmaceuticals Conference

  4/17/2006

• SuperGen, Inc. Announces 2006 First Quarter Financial Results Webcast

  4/13/2006

• SuperGen, Inc. Announces Results From Combination Study In CLL Published In The Journal Of Clinical Oncology

  3/14/2006

• SuperGen, Inc. To Present At Wedbush Morgan Small Cap Conference

  2/24/2006

• SuperGen, Inc. Reports 2005 Fourth Quarter And Year-End Financial Results

  2/24/2006

• SuperGen, Inc. Announces 2005 Fourth Quarter And Year End Financial Results Webcast

  2/21/2006

• SuperGen, Inc. To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/7/2006

• SuperGen, Inc. To Acquire Montigen Pharmaceuticals Inc. In A $18 Million Deal

  1/27/2006

• SuperGen, Inc. Announces Withdrawal Of Orathecin(TM) Marketing Authorization Application

  1/20/2006

• MGI Pharma Inc. And SuperGen, Inc. Release: Dacogen(TM) (Decitabine) Injection Complete Response Accepted For Review By U.S. FDA

  12/16/2005

• MGI Pharma Inc. And SuperGen, Inc. Dacogen(TM) (Decitabine) Injection Data Presented At American Society Of Hematology Annual Meeting

  12/12/2005

• SuperGen, Inc. Release: Studies Of Nipent(R) In Combination Cancer Therapies For Treatment Of Chronic Lymphocytic Leukemia And Graft-versus Host Disease (GVHD) Presented At American Society of Hematology Annual Meeting

  12/9/2005

• SuperGen, Inc. To Present At First Albany Capital Annual Growth Conference

  12/5/2005

• SuperGen, Inc. And MGI Pharma Inc., Pull European Drug Application

  11/15/2005

• MGI Pharma Inc. And SuperGen, Inc. Fall On Dacogen Delay

  10/27/2005

• SuperGen, Inc. To Present At C.E. Unterberg, Towbin Life Sciences Conference

  10/21/2005

• SuperGen, Inc. Reports 2005 Third Quarter Financial Results

  10/21/2005

• A Look Back At June In Biotech

  7/12/2004

• SuperGen Drug Posts Mixed Results, Stock Plunges

  3/31/2004